Give the gift of better outcomes! Your support helps people get the cancer screenings they need.

امروز اهدا کنید

منو

اهدا کنید

سردرگمی در مورد پوشش بیمه برای غربالگری سرطان دهانه رحم باعث از دست رفتن غربالگری می شود


افیا انتشار فوری

کایرا مایستر
703-836-1746
kyra.meister@preventcancer.org

اسکندریه، ویرجینیا - Cervical cancer: What was once the leading cause of cancer deaths among women in the U.S. is now one of the most preventable cancers thanks to the human papillomavirus (HPV) vaccine and cervical cancer screening.1 But confusion around the cost of cervical cancer screening is contributing to missed screenings, according to the annual Early Detection Survey from the Prevent Cancer Foundation®. Survey participants cited an inability to afford the cost (29%) as the top reason for not being up to date on their cervical cancer screening.

The 2023 survey shows 41% of American women are not up to date on cervical cancer screenings.2 This indicates an urgent need to discuss the cost of cervical cancer screening, as many people may be unaware cervical cancer screenings are covered through Medicaid and most private insurance plans. Increased understanding of the costs could mean fewer people miss out on essential preventive care.

Insurers are required to cover cervical cancer screenings for anyone with a cervix aged 21-65 because the U.S. Preventive Services Task Force (USPSTF) has issued it an “A” grade. Let’s break that down: 

  • The USPSTF—a group of medical experts who establish recommendations on certain health services, such as cancer screenings—assign a letter grade (A, B, C, D or I) on whether the services should be performed.  
  • Per the Affordable Care Act, Medicaid and private insurers are required to cover services, without copay, that are given an “A” or “B” grade.  
  • That means, under current law, if you have health insurance and you have a cervix, your cervical cancer screenings are covered.

In May 2018, the World Health Organization (WHO) announced a global call for action to eliminate cervical cancer within the next century, with achievable goals to be reached by 2030. While advances towards this goal have been made worldwide, significant disparities exist. The elimination of cervical cancer will be severely hindered without proper education across all populations about screening, insurance coverage and HPV vaccination.

Cervical cancer is most often caused by HPV infection, which can often be prevented with the HPV vaccine. All children should receive the HPV vaccine between ages 9-12. “Catch-up” vaccination is also recommended for teens and young adults up to age 26. If the HPV vaccine is given as recommended, it can prevent more than 90% of HPV-related cancers, including more than 90% of cervical cancers.3 Anyone with a cervix, regardless of vaccination status, should be screened for cervical cancer per recommendations.

People of average risk should follow these guidelines:

From ages 21 to 29: Have a Pap test every 3 years. (With a Pap test, you can find and remove precancerous cells before cancer develops.)

From ages 30 to 65: یکی از این گزینه ها را داشته باشید: 

  • هر 3 سال یکبار آزمایش پاپ به تنهایی انجام دهید. 
  • آزمایش HPV پرخطر به تنهایی هر 5 سال یکبار. 
  • تست HPV پرخطر با تست پاپ (تست همزمان) هر 5 سال یکبار.

After age 65: Talk with your health care provider about whether you still need to be screened.

If you are at higher risk for cervical cancer because of a suppressed immune system (for example, from HIV infection, organ or stem-cell transplant or long-term steroid use), because you were exposed to DES در رحم یا به دلیل اینکه سرطان دهانه رحم یا شرایط پیش سرطانی خاصی داشته اید، ممکن است نیاز به غربالگری بیشتر داشته باشید. توصیه های ارائه دهنده مراقبت های بهداشتی خود را دنبال کنید.

The cost of screening may still be a concern for those who are uninsured. Fortunately, there are free and low-cost screening options available in many communities. Early Detection = Better Outcomes, and everyone deserves an opportunity to check their health and prevent cancer or detect it early.

اطلاعات و منابع مربوط به همه انواع سرطان مورد مطالعه در بررسی تشخیص زودهنگام 2023 - از جمله اطلاعات مربوط به غربالگری‌های مربوطه - را می‌توانید در این آدرس مشاهده کنید. www.preventcancer.org/betteroutcomes. The Prevent Cancer Foundation will release updated results from the 2024 Early Detection Survey in April. For more information about cervical cancer and ways to reduce your risk, visit www.preventcancer.org/cervical.

1National Center for Chronic Disease Prevention and Health Promotion

2غربالگری های سرطان مورد مطالعه در این نظرسنجی برای سرطان سینه، سرطان دهانه رحم، سرطان کولورکتال، سرطان دهان، سرطان ریه، سرطان پروستات، سرطان پوست و سرطان بیضه بود.

3National Center for Immunization and Respiratory Diseases

###

درباره بنیاد پیشگیری از سرطان®

بنیاد پیشگیری از سرطان® است تنها ایالات متحده-مستقر سازمان غیر انتفاعی صرفا اختصاصی به سرطان پیشگیری و زودهنگام تشخیص. از طریق تحقیق، آموزش، تماس با ما و وکالت, ما به افراد بی‌شماری کمک کرده‌ایم تا از تشخیص سرطان اجتناب کنند یا سرطان خود را به‌اندازه کافی زود تشخیص دهند تا با موفقیت درمان شوند. ما رانده می شویم چشم انداز جهانی که در آن سرطان قابل پیشگیری است، قابل تشخیص و قابل ضرب و شتم برای همه

این بنیاد در حال افزایش است تا با چالش کاهش مرگ و میر ناشی از سرطان تا 40% تا سال 2035 مقابله کند. ما هستیم متعهد به سرمایه گذاری $20 میلیون برای فناوری های نوآورانه برای تشخیص زودهنگام و پیشرفت سرطان است چندغربالگری سرطان، $10 میلیون برای گسترش غربالگری سرطان و دسترسی به واکسیناسیون از نظر پزشکی جوامع محروم، و $10 میلیون برای آموزش مردم در مورد گزینه های غربالگری و واکسیناسیون.

برای اطلاعات بیشتر لطفا مراجعه کنید به www.preventcancer.org.